WebbSolid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies Mubashar Rehman,1–3 Ayesha Ihsan,2 Asadullah Madni,1 Sadia Zafar Bajwa,2 Di Shi,3 Thomas J Webster,3,4 Waheed S Khan2 1Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab, Pakistan; … Webb15 juli 2024 · Funding, Valuation & Revenue. 3 Fundings. Shape Therapeutics's latest funding round was a Series B for $112M on July 15, 2024. Date. Round. Amount. Investors. Valuation. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.
A review of proton therapy – Current status and future directions
WebbExpertise in coordination, inorganic, organometallic, organic, peptide, and bioconjugation chemistry including synthesis, purification, and various analytical and spectroscopic tools: multinuclear... Webbför 2 dagar sedan · Thrilled and humbled to represent the phenomenal scientists at ShapeTX as we continue to advance our RNA technology platforms. #shapelife 15 comments on LinkedIn smart card job
JPM Healthcare Conference: Shape, Korro, and Ionis Present …
WebbMaryland 161 views, 9 likes, 2 loves, 29 comments, 1 shares, Facebook Watch Videos from American Academy for Oral & Systemic Health: Join us on... WebbShape Therapeutics (ShapeTx) is a development-stage biotechnology company establishing itself as the leader in next-generation gene therapy. Our novel technology platform enables direct in vivo targeting/modification of RNA by leveraging ADARs (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and immune-stealth adeno … WebbBack in University...just on the other side of the podium! 😄 Last week I had the great opportunity to run some sessions on GMP Manufacturing of Cell… 10 تعليقات على LinkedIn hillary hair socks